A evolução do mercado farmacêutico brasileiro no tratamento do glaucoma nos últimos 30 anos

• Autor(a) principal: Souza Filho, João Pessoa de [UNIFESP]
• Data de Publicação: 2003
• Outros Autores: Dias, Ana Beatriz Toledo [UNIFESP], Lima Filho, Acácio Alves de Souza [UNIFESP], Sartori, Marta Filippi, Martins, Maria Cristina [UNIFESP]
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Institucional da UNIFESP
• Texto Completo: http://dx.doi.org/10.1590/S0004-27492003000700014; http://repositorio.unifesp.br/handle/11600/1946
• topic: Glaucoma; Drug costs; Drug industry; Ophthalmic solutions; Antihypertensive agents; Glaucoma; Custos de medicamentos; Industria farmacêutica; Soluções oftálmicas; Anti-hipertensivos

PURPOSE: To analyze price variations of drugs used to control glaucoma, during the last 30 years, at 10-year intervals. METHODS: Drugs to treat glaucoma, as well as their presentations and laboratories were selected from the 1972, 1982, 1992 and 2002 editions of the Dictionary of Pharmaceutical Specialties. The price of medicines in the Brazilian market were analyzed, in the different decades, using the pharmaceutical guide Brasíndice. For analysis of the data, the prices were converted to American dollars and the relationship between the medicine and the minimum wage was analyzed. As unit of the product, the values per milliliter, oral tablet or gram, depending on the presentation, were considered. RESULTS: The number of laboratories and antiglaucoma medications varied in the last thirty years. Drugs such as acetazolamide and pilocarpine still continue to be used. Parasympathomimetic drugs have predominantly been used in the first years of the study, and the beta-blockers in the last years. The average cost of available medications in the market has increased in the last decade. CONCLUSION: The price of antiglaucoma drugs varied considerably in the studied period as well as the type of drug used in the treatment.